Scientists Identify Key Protein Triggering Severe Illness in Mpox Cases
Table of Contents
A groundbreaking new study has pinpointed the AIM2 protein as a critical factor in the severity of Mpox infections, offering a potential pathway for developing targeted vaccines and treatments. Published on November 25, 2025, in the journal Cell and Molecular Immunology, the research provides the first experimental evidence linking AIM2 to the excessive inflammatory response that can lead to serious complications and, in rare cases, death from the virus.
Unraveling the Inflammatory Response to Mpox
Researchers at the Korea Disease Control and Prevention Agency’s National Institute of Health, in collaboration with teams from the Ulsan National Institute of Science and Technology and Sungkyunkwan University, discovered that the AIM2 protein acts as a key sensor, directly recognizing the DNA of the monkeypox virus. While other DNA-sensing proteins exist within the body, this study demonstrates that AIM2 is uniquely responsible for initiating a strong inflammatory reaction to the virus.
Currently, the fatality rate for Mpox remains around 3%, but a dangerous overreaction of the immune system – often referred to as a cytokine storm – can quickly escalate the illness, damaging healthy tissues and proving fatal. This phenomenon is tragically familiar from severe cases of influenza and coronavirus infections.
How AIM2 Drives Inflammation
The research details the process by which the AIM2 protein triggers this damaging inflammatory cascade. According to the study, when activated by viral DNA, AIM2 forms inflammatory bodies – protein complexes that rapidly assemble within cells upon detecting an infection. These inflammatory bodies then activate the caspase-1 enzyme, leading to cell destruction and the release of inflammatory signaling substances.
Experiments conducted by the team showed that inhibiting AIM2 significantly reduced both the inflammatory response and cell death in mouse lung tissue. This suggests that blocking AIM2’s activity could be a viable therapeutic strategy for mitigating the severity of Mpox infections.
Implications for Mpox Pandemic Preparedness
“This study is significant in that it is the first case of experimentally identifying AIM2 as the starting material that causes an excessive inflammatory response in monkeypox virus infection,” stated a senior official from the Korea Disease Control and Prevention Agency. “By identifying the molecular mechanism of the severity and inflammatory response caused by monkeypox virus, we have established a scientific basis for the development of vaccines and treatments to prepare for the Mpox pandemic.”
The findings represent a crucial step forward in understanding the complex interplay between the virus and the human immune system. Researchers are optimistic that this knowledge will accelerate the development of more effective interventions to combat Mpox and prevent future outbreaks. The Korea Disease Control and Prevention Agency affirmed its commitment to continuing research efforts, with the ultimate goal of producing both vaccines and treatments for the virus.
